Literature DB >> 26409273

Developments in Impact Assessment of New Diagnostic Algorithms for Tuberculosis Control.

Ivor Langley1, S Bertel Squire1, Russell Dacombe2, Jason Madan3, Jose Roberto Lapa e Silva4, Draurio Barreira5, Rafael Galliez4, Martha Maria Oliveira6, Paula I Fujiwara7, Afrânio Kritski4.   

Abstract

A modified presentation of the impact assessment framework is proposed that improves accessibility while continuing to provide a checklist of the evidence needed to support policy decisions on the implementation of new tools for the diagnosis of tuberculosis.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  diagnostics; impact assessment; modeling; tuberculosis

Mesh：

Year:  2015        PMID： 26409273     DOI： 10.1093/cid/civ580

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  4 in total

1.  Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia.

Authors:  Abraham Tesfaye; Daniel Fiseha; Dawit Assefa; Eveline Klinkenberg; Silvia Balanco; Ivor Langley
Journal:  BMC Infect Dis       Date:  2017-05-02       Impact factor: 3.090

2.  Eliminating tuberculosis in Latin America: making it the point.

Authors:  Raquel Duarte; Denise Rossato Silva; Adrian Rendon; Tatiana Galvẫo Alves; Marcelo Fouad Rabahi; Rosella Centis; Afrânio Kritski; Giovanni Battista Migliori
Journal:  J Bras Pneumol       Date:  2018-04       Impact factor: 2.624

3.  Modelling the impact of chest X-ray and alternative triage approaches prior to seeking a tuberculosis diagnosis.

Authors:  Abu A M Shazzadur Rahman; Ivor Langley; Rafael Galliez; Afrânio Kritski; Ewan Tomeny; S Bertel Squire
Journal:  BMC Infect Dis       Date:  2019-01-28       Impact factor: 3.090

4.  Clinical Impact of the Line Probe Assay and Xpert® MTB/RIF Assay in the Presumptive Diagnosis of Drug-Resistant Tuberculosis in Brazil: A Pragmatic Clinical Trial.

Authors:  Afranio Kritski; Maria Martha Oliveira; Isabela Neves de Almeida; Daniela Ramalho; Monica Kramer de Noronha Andrade; Monica Carvalho; Pryscila Fernandes Campino Miranda; Margareth Pretti Dalcolmo; Jose Ueleres Braga; Tania Brígido; Eliene Mesquita; Claudia Dias; Aglae Gambirasio; Joao Baptista Souza Filho; Anne Detjen; Patrick Peter John Phillips; Ivor Langley; Paula Fujiwara; Stephen Bertel Squire
Journal:  Rev Soc Bras Med Trop       Date:  2022-02-25       Impact factor: 1.581
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.